EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Selective Pro‐Oxidant Drives Redox Reprogramming to Induce Ferroptosis and Immune Remodeling in Glioblastoma

Shilpi Singh iD, Iteeshree Mohapatra iD, Katelyn Kim iD, Raza Ali Naqvi iD, Devanjan Dey iD, Laura Mohapatra iD, Davis Seelig iD, Afsar R Naqvi iD, Amar Singh iD, Kathleen Boris-Lawrie iD, Stefan Kim iD, Gatikrushna Singh iD

Smart Medicine · 2026-10 · 5 (5)

DOI: 10.1002/smmd.70058 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Smart Medicine, online erschienen am 08.10.2026. Verfasst von Shilpi Singh und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery University of Minnesota Minneapolis Minnesota USA. Die Arbeit nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Minnesota.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma remains a highly lethal malignancy characterized by profound therapeutic resistance driven, in part, by adaptive redox homeostasis. Although elevated reactive oxygen species support tumor progression, glioblastoma relies on robust antioxidant systems including the SLC7A11 ‐ GPX4 axis to buffer oxidative stress, creating a targetable vulnerability. Here, we investigate Rosasina , a sodium‐chlorite (NaClO 2 )‐derived, redox‐active small molecule, as a selective pro‐oxidant strategy to disrupt glioblastoma antioxidant resilience and induce ferroptotic cell death. Rosasina preferentially increased intracellular ROS in glioblastoma cells relative to normal human astrocytes, with hydrogen peroxide representing the predominant ROS species. This oxidative shift was accompanied by expansion of the labile iron pool and enhanced lipid peroxidation. In orthotopic glioblastoma models, Rosasina was well tolerated, significantly reduced tumor growth, prolonged survival, and exhibited no evidence of treatment‐related systemic toxicity, with preserved histological integrity of major organs. Mechanistically, Rosasina induces a coordinated pro‐ferroptotic transcriptional program, characterized by upregulation of iron uptake and lipid peroxidation pathways ( NCOA4, NOX5, ACSL4, TFRC ), alongside suppression of antioxidant defenses, including GPX4, GCH1, SCD1 , and SLC7A11 . In addition to its tumor‐intrinsic effects, Rosasina promoted macrophage polarization toward an anti‐tumor, pro‐inflammatory M1‐like phenotype without compromising macrophage viability, suggesting a potential role in tumor immune microenvironment reprogramming. Collectively, these findings establish Rosasina as a redox‐directed therapeutic that selectively exploits the oxidative vulnerabilities of glioblastoma to induce ferroptosis simultaneously promoting antitumor immune reprogramming. This study provides a mechanistic framework for the development of redox‐targeted therapies for glioblastoma.

Schlagwörter

Stichwörter der Autor:innen

anti‐tumor immunityferroptosisglioblastomamacrophage polarizationoxidative stresspro‐oxidantreactive oxygen species

Autor:innen und Institutionen

  • Department of Neurosurgery University of Minnesota Minneapolis Minnesota USA.
  • Bimeda Biologicals Oakdale Minnesota USA.
  • Department of Periodontics, College of Dentistry University of Illinois Chicago Chicago Illinois USA.
  • Department of Surgery Schulze Diabetes Institute, University of Minnesota Minneapolis Minnesota USA.
  • Department of Veterinary Clinical Sciences, College of Veterinary Medicine University of Minnesota Saint Paul Minnesota USA.
  • Department of Veterinary and Biomedical Sciences University of Minnesota Saint Paul Minnesota USA.

ORCID-Profile: Shilpi Singh, Iteeshree Mohapatra, Katelyn Kim, Raza Ali Naqvi, Devanjan Dey, Laura Mohapatra, Davis Seelig, Afsar R Naqvi, Amar Singh, Kathleen Boris-Lawrie, Stefan Kim, Gatikrushna Singh

Förderung

  • University of Minnesota

Zitieren

APA

Singh, S., Mohapatra, I., Kim, K., Naqvi, R. A., Dey, D., Mohapatra, L., Seelig, D., Naqvi, A. R., Singh, A., Boris-Lawrie, K., Kim, S., & Singh, G. (2026). A Selective Pro‐Oxidant Drives Redox Reprogramming to Induce Ferroptosis and Immune Remodeling in Glioblastoma. Smart Medicine, 5(5). https://doi.org/10.1002/smmd.70058

Vancouver

Singh S, Mohapatra I, Kim K, Naqvi RA, Dey D, Mohapatra L, et al. A Selective Pro‐Oxidant Drives Redox Reprogramming to Induce Ferroptosis and Immune Remodeling in Glioblastoma. Smart Medicine. 2026;5(5). doi:10.1002/smmd.70058

BibTeX
@article{Singh2026,
  author = {Singh, Shilpi and Mohapatra, Iteeshree and Kim, Katelyn and Naqvi, Raza Ali and Dey, Devanjan and Mohapatra, Laura and Seelig, Davis and Naqvi, Afsar R and Singh, Amar and Boris-Lawrie, Kathleen and Kim, Stefan and Singh, Gatikrushna},
  title = {A Selective Pro‐Oxidant Drives Redox Reprogramming to Induce Ferroptosis and Immune Remodeling in Glioblastoma},
  journal = {Smart Medicine},
  year = {2026},
  volume = {5},
  number = {5},
  doi = {10.1002/smmd.70058}
}
Kostenlos starten →